MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $78,000 | -1.3% | 917 | -42.4% | 0.00% | 0.0% |
| Q3 2019 | $79,000 | +102.6% | 1,592 | +45.4% | 0.00% | – |
| Q2 2019 | $39,000 | +30.0% | 1,095 | +0.6% | 0.00% | – |
| Q1 2019 | $30,000 | +42.9% | 1,088 | -5.6% | 0.00% | – |
| Q4 2018 | $21,000 | -41.7% | 1,153 | -5.1% | 0.00% | – |
| Q3 2018 | $36,000 | 0.0% | 1,215 | +22.9% | 0.00% | – |
| Q2 2018 | $36,000 | -5.3% | 989 | -14.4% | 0.00% | -100.0% |
| Q1 2018 | $38,000 | +8.6% | 1,155 | -6.2% | 0.00% | – |
| Q4 2017 | $35,000 | -10.3% | 1,231 | +16.8% | 0.00% | -100.0% |
| Q3 2017 | $39,000 | 0.0% | 1,054 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $39,000 | -27.8% | 1,025 | -6.8% | 0.00% | 0.0% |
| Q1 2017 | $54,000 | +35.0% | 1,100 | -6.8% | 0.00% | 0.0% |
| Q4 2016 | $40,000 | -21.6% | 1,180 | -11.4% | 0.00% | 0.0% |
| Q3 2016 | $51,000 | +24.4% | 1,332 | +4.1% | 0.00% | 0.0% |
| Q2 2016 | $41,000 | – | 1,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,752,000 | $58,919,000 | 16.72% |
| Antipodean Advisors LLC | 467,223 | $15,713,000 | 9.50% |
| BRIDGER MANAGEMENT, LLC | 2,412,501 | $81,132,000 | 5.24% |
| Signpost Capital Advisors, LP | 219,998 | $7,399,000 | 3.90% |
| Camber Capital Management LP | 2,000,000 | $67,260,000 | 3.25% |
| Partner Investment Management, L.P. | 50,808 | $1,709,000 | 2.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 368,392 | $12,389,000 | 2.77% |
| PFM Health Sciences, LP | 2,618,754 | $88,069,000 | 2.66% |
| IMA Wealth, Inc. | 99,569 | $3,300,000 | 2.07% |
| First Light Asset Management, LLC | 125,889 | $4,234,000 | 1.96% |